Exposure to ALS-FTD-CSF generates TDP-43 aggregates in glioblastoma cells through exosomes and TNTs-like structure

Oncotarget

Volumn 6, Issue 27, 2015, Pages 24178-24191

  Ding, Xuebing ^a   Ma, Mingming ^b,c   Teng, Junfang ^a   Teng, Robert K F ^d   Zhou, Shuang ^c   Yin, Jingzheng ^a   Fonkem, Ekokobe ^e   Huang, Jason H ^e   Wu, Erxi ^c   Wang, Xuejing ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

^c NORTH DAKOTA STATE UNIVERSITY   (United States)

^d CALIFORNIA STATE UNIVERSITY   (United States)

^e TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

ALS; Exosomes; FTD; TDP 43; Tunneling nanotubes

Indexed keywords

TAR DNA BINDING PROTEIN; DNA BINDING PROTEIN; NANOTUBE; PRION;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; ARTICLE; AUTOPHAGY; BRAIN CELL CULTURE; CARBOXY TERMINAL SEQUENCE; CEREBROSPINAL FLUID CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; EXOSOME; FEMALE; FRONTOTEMPORAL DEMENTIA; GLIOBLASTOMA CELL LINE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MALE; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; CELL CULTURE; CELL PROLIFERATION; CEREBROSPINAL FLUID; CHEMISTRY; FLUORESCENCE MICROSCOPY; GLIOBLASTOMA; METABOLISM; MIDDLE AGED; PRION; TUMOR CELL LINE;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; AUTOPHAGY; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; DNA-BINDING PROTEINS; EXOSOMES; FEMALE; FRONTOTEMPORAL DEMENTIA; GLIOBLASTOMA; HUMANS; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; NANOTUBES; PRIONS;

EID: 84943414298     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.4680     Document Type: Article

References (58)

1. Elman LB, McCluskey L and Grossman M. Motor neuron disease and frontotemporal lobar degeneration:a tale of two disorders linked to TDP-43. Neuro-Signals. 2008; 16:85-90.
2. Armstrong RA and Cairns NJ. A morphometric study of the spatial patterns of TDP-43 immunoreactive neuronal inclusions in frontotemporal lobar degeneration (FTLD) with progranulin (GRN) mutation. Histology and histopathology. 2011;26:185-190.
3. Collins M, Riascos D, Kovalik T, An J, Krupa K, Hood BL, Conrads TP, Renton AE, Traynor BJ and Bowser R. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients. Acta neuropathologica. 2012; 124:717-732.
4. van Langenhove T, van der Zee J and van Broeckhoven C. The molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum. Annals of medicine. 2012;44:817-28.
5. Baloh RH. TDP-43:the relationship between protein aggregation and neurodegeneration in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. The FEBS journal. 2011;278:3539-3549.
6. Dewey CM, Cenik B, Sephton CF, Johnson BA, Herz J and Yu G. TDP-43 aggregation in neurodegeneration:Are stress granules the key? Brain research. 2012;1462:16-25.
7. Cohen TJ, Lee VM and Trojanowski JQ. TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies. Trends in molecular medicine. 2011; 17:659-667.
8. Ugras SE and Shorter J. RNA-Binding Proteins in Amyotrophic Lateral Sclerosis and Neurodegeneration. Neurology research international. 2012;2012:432780.
9. Kanouchi T, Ohkubo T and Yokota T. Can regional spreading of amyotrophic lateral sclerosis motor symptoms be explained by prion-like propagation? Journal of neurology, neurosurgery, and psychiatry. 2012;83:739-45.
10. Nonaka T, Masuda-Suzukake M, Arai T, Hasegawa Y, Akatsu H, Obi T, Yoshida M, Murayama S, Mann DM, Akiyama H and Hasegawa M. Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell reports. 2013;4:124-134.
11. Pradat PF and Bruneteau G. Classical and atypical clinical features in amyotrophic lateral sclerosis [Article in French]. Revue neurologique. 2006;162 Spec No 2:4S17-14S24.
12. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J and Benson DF. Frontotemporal lobar degeneration:a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546-1554.
13. Wang X, Ma M, Teng J, Zhang J, Zhou S, Zhang Y, Wu E and Ding X. Chronic exposure to cerebrospinal fluid of multiple system atrophy in neuroblastoma and glioblastoma cells induces cytotoxicity via ER stress and autophagy activation. Oncotarget. 2015;6:13278-13294.
14. Street JM, Barran PE, Mackay CL, Weidt S, Balmforth C, Walsh TS, Chalmers RT, Webb DJ and Dear JW. Identification and proteomic profiling of exosomes in human cerebrospinal fluid. Journal of translational medicine. 2012;10:5.
15. Goedert M, Clavaguera F and Tolnay M. The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends in neurosciences. 2010;33:317-325.
16. Gangoda L, Boukouris S, Liem M, Kalra H and Mathivanan S. Extracellular vesicles including exosomes are mediators of signal transduction:Are they protective or pathogenic? Proteomics. 2014;15:260-271.
17. Suzuki H, Lee K and Matsuoka M. TDP-43-induced death is associated with altered regulation of BIM and Bcl-xL and attenuated by caspase-mediated TDP-43 cleavage. The Journal of biological chemistry. 2011;286:13171-13183.
18. Che MX, Jiang YJ, Xie YY, Jiang LL and Hu HY. Aggregation of the 35-kDa fragment of TDP-43 causes formation of cytoplasmic inclusions and alteration of RNA processing. FASEB journal :official publication of the Federation of American Societies for Experimental Biology. 2011;25:2344-2353.
19. Yang C, Tan W, Whittle C, Qiu L, Cao L, Akbarian S and Xu Z. The C-terminal TDP-43 fragments have a high aggregation propensity and harm neurons by a dominantnegative mechanism. PloS one. 2010;5:e15878.
20. Ruble BK, Richards JL, Cheung-Lau JC and Dmochowski IJ. Mismatch Discrimination and Efficient Photomodulation with Split 10-23 DNAzymes. Inorganica chimica acta. 2012;380:386-391.
21. Polymenidou M and Cleveland DW. The seeds of neurodegeneration:prion-like spreading in ALS. Cell. 2011; 147:498-508.
22. Gousset K, Schiff E, Langevin C, Marijanovic Z, Caputo A, Browman DT, Chenouard N, de Chaumont F, Martino A, Enninga J, Olivo-Marin JC, Mannel D and Zurzolo C. Prions hijack tunnelling nanotubes for intercellular spread. Nature cell biology. 2009;11:328-336.
23. Costanzo M, Abounit S, Marzo L, Danckaert A, Chamoun Z, Roux P and Zurzolo C. Transfer of polyglutamine aggregates in neuronal cells occurs in tunneling nanotubes. Journal of cell science. 2013;126:3678-3685.
24. Armstrong RA and Cairns NJ. Different molecular pathologies result in similar spatial patterns of cellular inclusions in neurodegenerative disease:a comparative study of eight disorders. Journal of Neural Transmission. 2012;119:1551-1560.
25. Zhang YJ, Xu YF, Dickey CA, Buratti E, Baralle F, Bailey R, Pickering-Brown S, Dickson D and Petrucelli L. Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2007; 27:10530-10534.
26. Dormann D, Capell A, Carlson AM, Shankaran SS, Rodde R, Neumann M, Kremmer E, Matsuwaki T, Yamanouchi K, Nishihara M and Haass C. Proteolytic processing of TAR DNA binding protein-43 by caspases produces C-terminal fragments with disease defining properties independent of progranulin. Journal of neurochemistry. 2009;110:1082-1094.
27. Zhang YJ, Xu YF, Cook C, Gendron TF, Roettges P, Link CD, Lin WL, Tong J, Castanedes-Casey M, Ash P, Gass J, Rangachari V, Buratti E, Baralle F, Golde TE, Dickson DW, et al. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proceedings of the National Academy of Sciences of the United States of America. 2009;106:7607-7612.
28. Geser F, Lee VM and Trojanowski JQ. Amyotrophic lateral sclerosis and frontotemporal lobar degeneration:a spectrum of TDP-43 proteinopathies. Neuropathology :official journal of the Japanese Society of Neuropathology. 2010; 30:103-112.
29. Liscic RM, Grinberg LT, Zidar J, Gitcho MA and Cairns NJ. ALS and FTLD:two faces of TDP-43 proteinopathy. European journal of neurology :the official journal of the European Federation of Neurological Societies. 2008; 15:772-780.
30. Yanez M, Galan L, Matias-Guiu J, Vela A, Guerrero A and Garcia AG. CSF from amyotrophic lateral sclerosis patients produces glutamate independent death of rat motor brain cortical neurons:protection by resveratrol but not riluzole. Brain research. 2011;1423:77-86.
31. Tarasiuk J, Kulakowska A, Drozdowski W, Kornhuber J and Lewczuk P. CSF markers in amyotrophic lateral sclerosis. Journal of Neural Transmission. 2012;119:747-757.
32. Deepa P, Shahani N, Alladi PA, Vijayalakshmi K, Sathyaprabha TN, Nalini A, Ravi V and Raju TR. Down regulation of trophic factors in neonatal rat spinal cord after administration of cerebrospinal fluid from sporadic amyotrophic lateral sclerosis patients. Journal of Neural Transmission. 2011;118:531-538.
33. Tortelli R, Ruggieri M, Cortese R, D'Errico E, Capozzo R, Leo A, Mastrapasqua M, Zoccolella S, Leante R, Livrea P, Logroscino G and Simone IL. Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis:a possible marker of disease severity and progression. European journal of neurology :the official journal of the European Federation of Neurological Societies. 2012;19:1561-1567.
34. Noto Y, Shibuya K, Sato Y, Kanai K, Misawa S, Sawai S, Mori M, Uchiyama T, Isose S, Nasu S, Sekiguchi Y, Fujimaki Y, Kasai T, Tokuda T, Nakagawa M and Kuwabara S. Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis:specificity, sensitivity, and a possible prognostic value. Amyotrophic lateral sclerosis :official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases. 2011;12:140-143.
35. Budini M, Buratti E, Stuani C, Guarnaccia C, Romano V, De Conti L and Baralle FE. Cellular model of TAR DNAbinding protein 43 (TDP-43) aggregation based on its C-terminal Gln/Asn-rich region. The Journal of biological chemistry. 2012;287:7512-7525.
36. Kasai T, Tokuda T, Ishigami N, Sasayama H, Foulds P, Mitchell DJ, Mann DM, Allsop D and Nakagawa M. Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Acta neuropathologica. 2009;117:55-62.
37. Kimura S, Hase K and Ohno H. The molecular basis of induction and formation of tunneling nanotubes. Cell and tissue research. 2013;352:67-76.
38. Zhang Y. Tunneling-nanotube:A new way of cell-cell communication. Communicative & integrative biology. 2011;4:324-325.
39. Wang Y, Cui J, Sun X and Zhang Y. Tunneling-nanotube development in astrocytes depends on p53 activation. Cell death and differentiation. 2011;18:732-742.
40. Barbeito LH, Pehar M, Cassina P, Vargas MR, Peluffo H, Viera L, Estevez AG and Beckman JS. A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain research Brain research reviews. 2004;47:263-274.
41. Tan CF, Piao YS, Kakita A, Yamada M, Takano H, Tanaka M, Mano A, Makino K, Nishizawa M, Wakabayashi K and Takahashi H. Frontotemporal dementia with co-occurrence of astrocytic plaques and tufted astrocytes, and severe degeneration of the cerebral white matter:a variant of corticobasal degeneration? Acta neuropathologica. 2005; 109:329-338.
42. Martin JA, Craft DK, Su JH, Kim RC and Cotman CW. Astrocytes degenerate in frontotemporal dementia:possible relation to hypoperfusion. Neurobiology of aging. 2001; 22:195-207.
43. Gallardo G, Barowski J, Ravits J, Siddique T, Lingrel JB, Robertson J, Steen H and Bonni A. An alpha2-Na/K ATPase/alpha-adducin complex in astrocytes triggers noncell autonomous neurodegeneration. Nature neuroscience. 2014;17:1710-1719.
44. Ferraiuolo L. The non-cell-autonomous component of ALS: new in vitro models and future challenges. Biochemical Society transactions. 2014;42:1270-1274.
45. Kruminis-Kaszkiel E, Wojtkiewicz J and Maksymowicz W. Glial-restricted precursors as potential candidates for ALS cell-replacement therapy. Acta neurobiologiae experimentalis. 2014;74:233-241.
46. Cai M, Lee KW, Choi SM and Yang EJ. TDP-43 modification in the hSOD1 amyotrophic lateral sclerosis mouse model. Neurological research. 2014;37:253-262.
47. Le Verche V. Familial and sporadic ALS astrocytes activate necroptosis in motor neurons [Article in French]. Medecine sciences. 2014;30:748-750.
48. Karki P, Smith K, Johnson J, Jr., Aschner M and Lee E. Role of transcription factor yin yang 1 in manganeseinduced reduction of astrocytic glutamate transporters: Putative mechanism for manganese-induced neurotoxicity. Neurochemistry international. 2014;S0197-0186(14)00185-5.
49. Pehar M, Beeson G, Beeson CC, Johnson JA and Vargas MR. Mitochondria-targeted catalase reverts the neurotoxicity of hSOD1G(9)(3)A astrocytes without extending the survival of ALS-linked mutant hSOD1 mice. PloS one. 2014;9:e103438.
50. Pirooznia SK, Dawson VL and Dawson TM. Motor neuron death in ALS:programmed by astrocytes? Neuron. 2014; 81:961-963.
51. Rojas F, Cortes N, Abarzua S, Dyrda A and van Zundert B. Astrocytes expressing mutant SOD1 and TDP43 trigger motoneuron death that is mediated via sodium channels and nitroxidative stress. Frontiers in cellular neuroscience. 2014;8:24.
52. Kreutzberg GW. Microglia:a sensor for pathological events in the CNS. Trends in neurosciences. 1996;19:312-318.
53. Ghavami S, Shojaei S, Yeganeh B, Ande SR, Jangamreddy JR, Mehrpour M, Christoffersson J, Chaabane W, Moghadam AR, Kashani HH, Hashemi M, Owji AA and Los MJ. Autophagy and apoptosis dysfunction in neurodegenerative disorders. Progress in neurobiology. 2014;112:24-49.
54. Korolchuk VI, Menzies FM and Rubinsztein DC. Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems. FEBS letters. 2010; 584:1393-1398.
55. Li L, Zhang X and Le W. Altered macroautophagy in the spinal cord of SOD1 mutant mice. Autophagy. 2008;4:290-293.
56. Sasaki S. Autophagy in spinal cord motor neurons in sporadic amyotrophic lateral sclerosis. Journal of neuropathology and experimental neurology. 2011;70:349-359.
57. Shi P, Wei Y, Zhang J, Gal J and Zhu H. Mitochondrial dysfunction is a converging point of multiple pathological pathways in amyotrophic lateral sclerosis. Journal of Alzheimer's disease :JAD. 2010;20 Suppl 2:S311-324.
58. Reyes NA, Fisher JK, Austgen K, VandenBerg S, Huang EJ and Oakes SA. Blocking the mitochondrial apoptotic pathway preserves motor neuron viability and function in a mouse model of amyotrophic lateral sclerosis. The Journal of clinical investigation. 2010;120:3673-3679.